Conjugated estrogens/norgestrel (CEEs/NG), sold under the brand name Prempak-C among others, is a combination of conjugated estrogens (CEEs), an estrogen, and norgestrel (NG), a progestin, which is used in menopausal hormone therapy in postmenopausal women.[1][2][3][4] It is taken by mouth and contains 0.625 or 1.25 mg CEEs and 150 μg NG (or 75 μg levonorgestrel) per tablet.[1][2][3][4] The medication is no longer marketed.[5][6]
 Estrone sulfate (major active component of conjugated estrogens) | |
 Levonorgestrel (active form of norgestrel) | |
| Combination of | |
|---|---|
| Conjugated estrogens | Estrogen |
| Norgestrel | Progestogen; Progestin |
| Clinical data | |
| Trade names | Prempak-C |
| Other names | CEEs/NG |
| Routes of administration | By mouth |
| Drug class | Estrogen; Progestin; Progestogen |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
See also
editReferences
edit- ^ a b Cartwright S, Godlee C (20 January 2012). Churchill's Pocketbook of General Practice E-Book. Elsevier Health Sciences. pp. 55–. ISBN 978-0-7020-5073-2.
- ^ a b Erkkola R (1 January 2006). The Menopause. Elsevier. pp. 265–. ISBN 978-0-444-51830-9.
- ^ a b Filshie M, Guillebaud J (22 October 2013). Contraception: Science and Practice. Elsevier Science. pp. 229–. ISBN 978-1-4831-6366-6.
- ^ a b Constanti A (17 February 1998). Basic Endocrinology for Students of Pharmacy and Allied Health Sciences. CRC Press. pp. 102–. ISBN 978-90-5702-250-0.
- ^ "Norgestrel".
- ^ "Levonorgestrel".
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |